Description:
NEUROFIBROMATOSIS, TYPE II; NF2
NEUROFIBROMIN 2; NF2
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases Hereditary Cancers |
Quantity |
25 µg |
Quantitation Method |
Please see our FAQ |
Biopsy Source
|
Peripheral vein
|
Cell Type
|
B-Lymphocyte
|
Tissue Type
|
Blood
|
Transformant
|
Epstein-Barr Virus
|
Sample Source
|
DNA from LCL
|
Race
|
White
|
Family History
|
N
|
Relation to Proband
|
proband
|
Confirmation
|
Molecular characterization before cell line submission to CCR
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by LINE assay |
|
Gene |
NF2 |
Chromosomal Location |
22q12.2 |
Allelic Variant 1 |
; NEUROFIBROMATOSIS, TYPE 2 |
Identified Mutation |
NF2 GENE DELETION |
|
Gene |
NF2 |
Chromosomal Location |
22q12.2 |
Allelic Variant 2 |
; NEUROFIBROMATOSIS, TYPE 2 |
Identified Mutation |
1026_1027delAG |
Remarks |
Clinically affected; unilateral moderate hearing loss and unilateral vestibular schwannoma; asymptomatic spinal tumors and schwannomas (right thumb, left wrist, right palm); founder mosaic for NF2: analysis of donor subject's tumor tissue showed that one allele has a total NF2 gene deletion and a second allele has a 2 bp deletion at nucleotide 1026 (c.1026_1027delAG) |
Gene Cards |
NF2 |
Gene Ontology |
GO:0005198 structural molecule activity |
|
GO:0005856 cytoskeleton |
|
GO:0005886 plasma membrane |
|
GO:0007605 perception of sound |
|
GO:0008092 cytoskeletal protein binding |
|
GO:0008285 negative regulation of cell proliferation |
|
GO:0045786 negative regulation of cell cycle |
NCBI Gene |
Gene ID:4771 |
NCBI GTR |
101000 NEUROFIBROMATOSIS, TYPE II; NF2 |
|
607379 NEUROFIBROMIN 2; NF2 |
OMIM |
101000 NEUROFIBROMATOSIS, TYPE II; NF2 |
|
607379 NEUROFIBROMIN 2; NF2 |
Omim Description |
ACOUSTIC NEURINOMA, BILATERAL; ACNNEUROFIBROMIN 2, INCLUDED |
|
ACOUSTIC SCHWANNOMAS, BILATERAL |
|
BILATERAL ACOUSTIC NEUROFIBROMATOSIS; BANF |
|
MERLIN, INCLUDED |
|
NEUROFIBROMATOSIS, CENTRAL TYPE |
|
NEUROFIBROMATOSIS, TYPE II; NF2 |
|
SCHWANNOMIN, INCLUDED; SCH, INCLUDED |
|
|